Literature DB >> 9225988

Chemokine receptors and HIV.

C C Broder1, R G Collman.   

Abstract

The discovery that chemokine receptors are the human cofactors required along with CD4 for fusion and infection by HIV has opened new directions in AIDS research on mechanisms of viral entry, tropism, and pathogenesis. A possible mechanism of co-receptor function has been demonstrated that involves the formation of a complex on the cell surface between the HIV-1 envelope, CD4, and the coreceptor. Functional studies indicate that this interaction is structurally complex, that it probably involves multiple domains of the coreceptor, and that different virus isolates interact with coreceptors in distinct ways. Other immunodeficiency viruses including simian immunodeficiency virus and feline immunodeficiency virus also utilize chemokine receptors for entry. The identification of genetic polymorphisms helps explain why some people, with alterations in the CCR5 gene that prevent expression, are protected from HIV-1 infection. The discovery of specific HIV-1 fusion coreceptor molecules has not only provided new insights into the mechanisms of viral entry and tropism, but also led to new avenues of investigation on strategies to block HIV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225988     DOI: 10.1002/jlb.62.1.20

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  38 in total

1.  Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.

Authors:  N Genois; B Barbeau; M Olivier; M J Tremblay
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc.

Authors:  Shigehiro Asano; Julia Gavrilyuk; Dennis R Burton; Carlos F Barbas
Journal:  ACS Med Chem Lett       Date:  2014-02-13       Impact factor: 4.345

3.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Authors:  R S Kornbluth; K Kee; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 4.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

5.  Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.

Authors:  M P Nair; K C Chadha; R G Hewitt; S Mahajan; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

6.  IL-10 up-regulates CCR5 gene expression in human monocytes.

Authors:  M Houle; M Thivierge; C Le Gouill; J Stankovà; M Rola-Pleszczynski
Journal:  Inflammation       Date:  1999-06       Impact factor: 4.092

7.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.

Authors:  O Meucci; A Fatatis; A A Simen; T J Bushell; P W Gray; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins.

Authors:  Kelsey J Metzger; Michael A Thomas
Journal:  BMC Evol Biol       Date:  2010-05-10       Impact factor: 3.260

9.  A detailed phylogenetic analysis of FIV in the United States.

Authors:  Eric A Weaver
Journal:  PLoS One       Date:  2010-08-09       Impact factor: 3.240

10.  CCR2-64I and CCR5Delta32 Polymorphisms in Korean Patients with Myasthenia Gravis.

Authors:  Hyun Sook Kim; Dae-Seong Kim; Eun Young Lee; Il-Nam Sunwoo; Young-Chul Choi
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.